CANC Tema Oncology ETF

2

NASDAQ | ETF

Price
$23.52
Decreased by -1.80%
Dollar volume (20D)
179.50 K
ADR%
1.57
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology.

The fund is non-diversified.

Top 20 Holdings

Asset Name Sector Industry Weight
LLY Eli Lilly and Company Healthcare Drug Manufacturers - General 5.44%
RHHBY Roche Holding Ltd ADR Healthcare Drug Manufacturers - General 5.30%
RVMD Revolution Medicines Inc Healthcare Biotechnology 5.10%
BMY Bristol-Myers Squibb Company Healthcare Drug Manufacturers - General 4.72%
AZN AstraZeneca PLC Healthcare Drug Manufacturers - General 4.56%
NOVN Novartis AG Healthcare Drug Manufacturers - General 4.32%
EXEL Exelixis Inc Healthcare Biotechnology 4.18%
BBIO BridgeBio Pharma Inc Healthcare Biotechnology 4.08%
ZLAB Zai Lab Ltd Healthcare Biotechnology 3.85%
NUVL Nuvalent Inc Healthcare Biotechnology 3.69%
4568 Daiichi Sankyo Co. Ltd. Healthcare Drug Manufacturers - General 3.23%
BGNE BeiGene Ltd Healthcare Biotechnology 3.08%
GMAB Genmab AS Healthcare Biotechnology 3.08%
AMGN Amgen Inc Healthcare Drug Manufacturers - General 3.04%
IMGN ImmunoGen Inc Healthcare Biotechnology 3.00%
SMMT Summit Therapeutics PLC Healthcare Biotechnology 2.96%
MRK Merck & Company Inc Healthcare Drug Manufacturers - General 2.95%
MRUS Merus BV Healthcare Biotechnology 2.90%
BPMC Blueprint Medicines Corp Healthcare Biotechnology 2.89%
ACLX Arcellx Inc Healthcare Biotechnology 2.77%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY